Summary
The metabolic effects of glucagon, administered i.v. in doses of 1 µg/kg, were evaluated in two groups of patients with endogenous hypertriglyceridemia (Types IV and V according to Fredrickson) with normal and reduced glucose tolerance and in a control group. Glucagon had a lipolytic effect, evaluated as the plasma increase of free fatty acids (FFA) during the first 20 min in normal subjects, but not in the two hyperlipemic groups. A negative correlation was observed between fasting IRI level and FFA mobilization. The ketogenic and hypotriglyceridemic effects of glucagon were demonstrated in normal and hyperlipemic groups. It would seem, therefore, that at the pharmacological doses injected, there is no resistance to the hypotriglyceridemic effect of glucagon in endogenous hypertriglyceridemia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Amatuzio D. S., Grande F., Wada S.: Effect of glucagon on the serum lipids in essential hyperlipemia and in hypercholesterolemia — Metabolism11, 1240, 1962.
Aubry F., Marcel L. Y., Davignon J.: Effects of glucagon on plasma lipids in different types of primary hyperlipoproteinemia — Metabolism23, 225, 1974.
Chiasson J. L., Liljenquist J. E., Sinclair-Smith B. C., Lacy W. W.: Gluconeogenesis from alanine in normal postabsorptive man. Intrahepatic stimulatory effect of glucagon — Diabetes24, 574, 1975.
Duncombe W. G.: Colorimetric microdetermination of nonesterified fatty acids in plasma — Clin. chim. Acta9, 112, 1964.
Eaton P. R.: Glucagon secretion and activity in the cobalt chloride-treated rat — Amer. J. Physiol.225, 67, 1973.
Eaton P. R., Schade D. S.: Glucagon resistance as a hormonal basis for endogenous hyperlipaemia — Lancet1, 973, 1973.
Eggstein M., Kreutz F. H.: Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe. I. Mitteilung (Prinzip, Durchführung und Besprechung der Methode) — Klin. Wschr.44, 262, 1966.
Elkeles R. S., Hambley J.: Glucagon resistance as a cause of hypertriglyceridaemia — Lancet2, 18, 1976.
Exton J. H., Park C. R.: Control of gluconeogenesis in liver. II. Effects of glucagon, catecholamines and adenosine 3′,5′-monophosphate on gluconeogenesis in the perfused rat liver — J. biol. Chem.243, 4189, 1968.
Fajans S. S., Conn J. W.: The early recognition of human diabetes mellitus — Ann. N.Y. Acad Sci.82, 208, 1959.
Herbert V., Lan K. S., Gottlieb C. W., Bleicher S. J.: Coated charcoal immunoassay of insulin — J. clin. Endocr.25, 1375, 1965.
Huggett A. S., Nixon D. A.: Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose — Lancet2, 368, 1957.
Liljenquist J. E., Bomboy J. D., Lewis S. B., Sinclair-Smith B. C., Felts P. W., Lacy W. W., Crofford O. B., Liddle G. W.: Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men — J. clin. Invest.53, 190, 1974.
McGarry J. D., Foster D. W.: Ketogenesis and its regulation — Amer. J. Med.61, 9, 1975.
Mellanby J., Williamson D. H.: β-Hydroxybutyrate — In:Bergmeyer H. V. (Ed.): Methoden der enzymatischen Analyse. Verlag-Chemie, Weinheim, 1970; p. 1772.
Noble R. P.: Electrophoretic separation of plasma lipoproteins in agarose gel — J. Lipid Res.9, 693, 1968.
Pozefsky T., Tancredi R. G., Moxley R. T., Dupré J., Tobin J. D.: Metabolism of forearm tissues in man. Studies with glucagon — Diabetes25, 128, 1976.
Pozza G., Pappalettera A., Melogli O., Viberti G., Ghidoni A.: Lipolytic effect of intraarterial injection of glucagon in man — Hormone metab. Res.3, 291, 1971.
Schade D. S., Eaton R. P.: The contribution of endogenous insulin secretion to the ketogenic response to glucagon in man — Diabetologia11, 555, 1975.
Schade D. S., Eaton R. P.: Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjects — Diabetes24, 502, 1975.
Schade D. S., Eaton R. P.: Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics — Diabetes24, 510, 1975.
Sokal J.: Glucagon — an essential hormone — Amer. J. Med.41, 331, 1966.
Tiengo A., Muggeo M., Assan R., Fedele D., Crepaldi G.: Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment — Metabolism24, 901, 1975.
Williamson D. H.: Alanine — In:Bergmeyer H. V. (Ed.): Methoden der enzymatischen Analyse. Verlag-Chemie, Weinheim, 1970; p. 1634.
Author information
Authors and Affiliations
Additional information
This work was supported in part by C.N.R. (Consiglio Nazionale delle Ricerche) Grant CT 77.01522.04.
Rights and permissions
About this article
Cite this article
Nosadini, R., Soldà, G., de Biasi, F. et al. Metabolic effects of glucagon in endogenous hypertriglyceridemia. Acta diabet. lat 15, 251–258 (1978). https://doi.org/10.1007/BF02590748
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02590748